Fagron Résultats passés
Passé contrôle des critères 5/6
Fagron has been growing earnings at an average annual rate of 7%, while the Healthcare industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 9.9% per year. Fagron's return on equity is 16.4%, and it has net margins of 9.5%.
Informations clés
7.0%
Taux de croissance des bénéfices
6.6%
Taux de croissance du BPA
Healthcare Croissance de l'industrie | 13.4% |
Taux de croissance des recettes | 9.9% |
Rendement des fonds propres | 16.4% |
Marge nette | 9.5% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Fagron NV (EBR:FAGR)
Oct 07Fagron NV's (EBR:FAGR) CEO Will Probably Find It Hard To See A Huge Raise This Year
May 07The Returns At Fagron (EBR:FAGR) Aren't Growing
Apr 17Is Fagron (EBR:FAGR) A Risky Investment?
Mar 15Earnings Tell The Story For Fagron NV (EBR:FAGR)
Feb 18Fagron (EBR:FAGR) Seems To Use Debt Quite Sensibly
Aug 11Be Wary Of Fagron (EBR:FAGR) And Its Returns On Capital
Jun 10Fagron (EBR:FAGR) Has Announced That It Will Be Increasing Its Dividend To €0.175
May 12An Intrinsic Calculation For Fagron NV (EBR:FAGR) Suggests It's 30% Undervalued
Apr 20Is Fagron (EBR:FAGR) A Risky Investment?
Apr 02Here's Why Fagron (EBR:FAGR) Can Manage Its Debt Responsibly
Oct 14Return Trends At Fagron (EBR:FAGR) Aren't Appealing
Jun 04Fagron (EBR:FAGR) Is Paying Out A Larger Dividend Than Last Year
May 13Is Fagron (EBR:FAGR) Using Too Much Debt?
Apr 13Slowing Rates Of Return At Fagron (EBR:FAGR) Leave Little Room For Excitement
Feb 16Fagron (EBR:FAGR) Has A Pretty Healthy Balance Sheet
Nov 18Fagron (EBR:FAGR) Is Experiencing Growth In Returns On Capital
Sep 25Are Investors Undervaluing Fagron NV (EBR:FAGR) By 45%?
Aug 30Fagron NV (EBR:FAGR) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 08Is Fagron (EBR:FAGR) A Risky Investment?
Jun 15Fagron NV (EBR:FAGR) Shares Could Be 49% Below Their Intrinsic Value Estimate
May 29The Returns At Fagron (EBR:FAGR) Aren't Growing
May 03Here's Why Fagron (EBR:FAGR) Can Manage Its Debt Responsibly
Mar 08Is Fagron NV (EBR:FAGR) A Smart Choice For Dividend Investors?
Feb 22The Returns At Fagron (EBR:FAGR) Provide Us With Signs Of What's To Come
Jan 31Is Fagron NV (EBR:FAGR) Popular Amongst Institutions?
Jan 14How Much Does Fagron's (EBR:FAGR) CEO Make?
Dec 27Are Investors Undervaluing Fagron NV (EBR:FAGR) By 25%?
Dec 14Fagron (EBR:FAGR) Seems To Use Debt Quite Sensibly
Nov 30Should You Be Excited About Fagron NV's (EBR:FAGR) 26% Return On Equity?
Nov 17Is Fagron (EBR:FAGR) Using Too Much Debt?
Aug 23Why Fagron NV (EBR:FAGR) Looks Like A Quality Company
Aug 10Should Fagron (EBR:FAGR) Be Disappointed With Their 64% Profit?
Jul 28Will Fagron (EBR:FAGR) Multiply In Value Going Forward?
Jul 14What Kind Of Shareholder Owns Most Fagron NV (EBR:FAGR) Stock?
Jun 30Ventilation des recettes et des dépenses
Comment Fagron gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 821 | 78 | 205 | 0 |
31 Mar 24 | 792 | 74 | 196 | 0 |
31 Dec 23 | 763 | 71 | 187 | 0 |
30 Sep 23 | 745 | 69 | 181 | 0 |
30 Jun 23 | 727 | 67 | 175 | 0 |
31 Mar 23 | 705 | 69 | 166 | 0 |
31 Dec 22 | 684 | 70 | 158 | 0 |
30 Sep 22 | 655 | 70 | 149 | 0 |
30 Jun 22 | 626 | 69 | 140 | 0 |
31 Mar 22 | 600 | 65 | 136 | 0 |
31 Dec 21 | 574 | 61 | 133 | 0 |
30 Sep 21 | 564 | 58 | 131 | 0 |
30 Jun 21 | 554 | 55 | 129 | 0 |
31 Mar 21 | 555 | 57 | 127 | 0 |
31 Dec 20 | 556 | 60 | 125 | 0 |
30 Sep 20 | 557 | 60 | 125 | 0 |
30 Jun 20 | 558 | 60 | 126 | 0 |
31 Mar 20 | 546 | 58 | 125 | 0 |
31 Dec 19 | 535 | 55 | 125 | 0 |
30 Jun 19 | 496 | 51 | 120 | 0 |
31 Mar 19 | 484 | 47 | 116 | 0 |
31 Dec 18 | 472 | 43 | 113 | 0 |
30 Jun 18 | 444 | 45 | 103 | 0 |
31 Mar 18 | 439 | 46 | 102 | 0 |
31 Dec 17 | 434 | 47 | 101 | 0 |
30 Sep 17 | 433 | 16 | 101 | 0 |
30 Jun 17 | 432 | -14 | 101 | 0 |
31 Mar 17 | 428 | -15 | 100 | 0 |
31 Dec 16 | 422 | -19 | 97 | 0 |
30 Sep 16 | 421 | -25 | 99 | 0 |
30 Jun 16 | 421 | -31 | 101 | 0 |
31 Mar 16 | 474 | -203 | 124 | 0 |
31 Dec 15 | 428 | -25 | 104 | 0 |
30 Sep 15 | 441 | 8 | 105 | 0 |
30 Jun 15 | 455 | 41 | 106 | 0 |
31 Mar 15 | 445 | 38 | 103 | 0 |
31 Dec 14 | 447 | 43 | 102 | 0 |
30 Sep 14 | 418 | 46 | 93 | 0 |
30 Jun 14 | 389 | 49 | 84 | 0 |
31 Mar 14 | 366 | 46 | 77 | 0 |
31 Dec 13 | 343 | 42 | 71 | 0 |
Des revenus de qualité: FAGR has high quality earnings.
Augmentation de la marge bénéficiaire: FAGR's current net profit margins (9.5%) are higher than last year (9.3%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: FAGR's earnings have grown by 7% per year over the past 5 years.
Accélération de la croissance: FAGR's earnings growth over the past year (15.5%) exceeds its 5-year average (7% per year).
Bénéfices par rapport au secteur d'activité: FAGR earnings growth over the past year (15.5%) exceeded the Healthcare industry 12.1%.
Rendement des fonds propres
ROE élevé: FAGR's Return on Equity (16.4%) is considered low.